Towards HCV extinction with modern HCV treatment? “Yes we can!”

por Torti, C, Focà, A, Carosi, G
Publicado 2012

Anti-inflammatory effect of procalcitonin on in vitro LPS-stimulated human PBMC

por Foca, A, Quirino, A, Pulicari, MC, Rametti, L, Matera, G, Liberto, MC
Publicado 2010

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients

por Focà, A, Liberto, MC, Rametti, L, Giancotti, A, Marascio, N, Quirino, A, Caroleo, S, Renzulli, A, Matera, G
Publicado 2012

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study

por Foca, A, Peronace, C, Marano, V, Barreca, GS, Lamberti, AG, Marascio, N, Giancotti, A, Puccio, R, Liberto, MC
Publicado 2014

Future research and collaboration: the “SINERGIE” project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)

por Torti, C, Zazzi, M, Abenavoli, L, Trapasso, F, Cesario, F, Corigliano, D, Cosco, L, Costa, C, Curia, RL, De Rosa, M, Foti, G, Giraldi, C, Leone, R, Liberto, MC, Lucchino, D, Marascio, N, Masciari, R, Matera, G, Pisani, V, Serrao, N, Surace, L, Zicca, E, Castelli, F, Ciccozzi, M, Puoti, M, Focà, A
Publicado 2012